Traders Sell Molina Healthcare (MOH) on Strength (MOH)

Share on StockTwits

Investors sold shares of Molina Healthcare, Inc. (NYSE:MOH) on strength during trading hours on Wednesday. $30.31 million flowed into the stock on the tick-up and $45.06 million flowed out of the stock on the tick-down, for a money net flow of $14.75 million out of the stock. Of all equities tracked, Molina Healthcare had the 0th highest net out-flow for the day. Molina Healthcare traded up $1.54 for the day and closed at $140.00

A number of analysts recently weighed in on the stock. Jefferies Financial Group raised shares of Molina Healthcare from a “hold” rating to a “buy” rating and raised their price target for the company from $152.00 to $169.00 in a report on Tuesday, November 13th. ValuEngine lowered shares of Molina Healthcare from a “buy” rating to a “hold” rating in a report on Thursday, November 1st. Zacks Investment Research raised shares of Molina Healthcare from a “hold” rating to a “strong-buy” rating and set a $155.00 target price for the company in a report on Tuesday, October 23rd. Morgan Stanley lifted their target price on shares of Molina Healthcare from $178.00 to $184.00 and gave the stock an “overweight” rating in a report on Thursday, October 18th. Finally, Evercore ISI began coverage on shares of Molina Healthcare in a report on Tuesday, October 9th. They set an “in-line” rating and a $158.00 target price for the company. One analyst has rated the stock with a sell rating, eight have assigned a hold rating, five have given a buy rating and one has given a strong buy rating to the company’s stock. Molina Healthcare has a consensus rating of “Hold” and an average target price of $131.92.

The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 0.78. The firm has a market capitalization of $8.73 billion, a P/E ratio of 250.00, a price-to-earnings-growth ratio of 1.52 and a beta of 1.53.

Molina Healthcare (NYSE:MOH) last released its earnings results on Wednesday, October 31st. The company reported $2.55 EPS for the quarter, topping analysts’ consensus estimates of $1.65 by $0.90. Molina Healthcare had a net margin of 1.27% and a return on equity of 30.50%. The firm had revenue of $4.70 billion during the quarter, compared to analyst estimates of $4.72 billion. During the same quarter in the previous year, the business earned ($1.62) EPS. The business’s quarterly revenue was down 6.6% compared to the same quarter last year. As a group, equities research analysts predict that Molina Healthcare, Inc. will post 8.12 earnings per share for the current year.

In other news, Director Charles Z. Fedak sold 3,795 shares of the business’s stock in a transaction on Monday, November 19th. The shares were sold at an average price of $120.74, for a total value of $458,208.30. Following the completion of the transaction, the director now owns 18,464 shares of the company’s stock, valued at approximately $2,229,343.36. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, insider James Woys purchased 25,000 shares of the firm’s stock in a transaction dated Wednesday, September 19th. The stock was purchased at an average cost of $148.79 per share, with a total value of $3,719,750.00. Following the acquisition, the insider now directly owns 17,203 shares in the company, valued at $2,559,634.37. The disclosure for this purchase can be found here. Insiders have sold a total of 8,845 shares of company stock valued at $1,143,830 in the last ninety days. Company insiders own 0.65% of the company’s stock.

Several hedge funds have recently made changes to their positions in the company. Vanguard Group Inc. grew its holdings in shares of Molina Healthcare by 14.0% in the 3rd quarter. Vanguard Group Inc. now owns 5,773,626 shares of the company’s stock valued at $858,538,000 after buying an additional 709,776 shares during the period. FMR LLC grew its holdings in shares of Molina Healthcare by 85.3% in the 2nd quarter. FMR LLC now owns 4,584,133 shares of the company’s stock valued at $448,970,000 after buying an additional 2,110,308 shares during the period. Renaissance Technologies LLC grew its holdings in shares of Molina Healthcare by 33.2% in the 3rd quarter. Renaissance Technologies LLC now owns 3,738,755 shares of the company’s stock valued at $555,953,000 after buying an additional 932,905 shares during the period. Acadian Asset Management LLC grew its holdings in shares of Molina Healthcare by 290.5% in the 3rd quarter. Acadian Asset Management LLC now owns 1,006,085 shares of the company’s stock valued at $149,607,000 after buying an additional 748,456 shares during the period. Finally, Capital International Investors acquired a new position in shares of Molina Healthcare in the 3rd quarter valued at $137,856,000.

ILLEGAL ACTIVITY WARNING: This story was originally posted by Zolmax and is the sole property of of Zolmax. If you are accessing this story on another publication, it was copied illegally and reposted in violation of United States and international copyright and trademark legislation. The legal version of this story can be accessed at https://zolmax.com/investing/traders-sell-molina-healthcare-moh-on-strength-moh/2744444.html.

About Molina Healthcare (NYSE:MOH)

Molina Healthcare, Inc provides Medicaid-related solutions to meet the health care needs of low-income families and individuals; and to assist state agencies in their administration of the Medicaid program in the United States. It operates through three segments: Health Plans, Molina Medicaid Solutions, and Other.

Further Reading: Price to Earnings Ratio (PE), For Valuing Stocks

Receive News & Ratings for Molina Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Molina Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

MCCORMICK & CO /SH NV  Shares Sold by Canada Pension Plan Investment Board
MCCORMICK & CO /SH NV Shares Sold by Canada Pension Plan Investment Board
ASOS PLC/ADR  Downgraded to “Sell” at Stifel Nicolaus
ASOS PLC/ADR Downgraded to “Sell” at Stifel Nicolaus
Northgate  Cut to Sell at Zacks Investment Research
Northgate Cut to Sell at Zacks Investment Research
Cynata Therapeutics  Upgraded to Buy by Zacks Investment Research
Cynata Therapeutics Upgraded to Buy by Zacks Investment Research
Plymouth Industrial Reit  Receives New Coverage from Analysts at Wedbush
Plymouth Industrial Reit Receives New Coverage from Analysts at Wedbush
Exxon Mobil Co.  Holdings Cut by CENTRAL TRUST Co
Exxon Mobil Co. Holdings Cut by CENTRAL TRUST Co


Leave a Reply

 
© 2006-2018 Zolmax.